Ionis Pharmaceuticals Stock Target Price and Analyst Consensus
IONS Stock | USD 43.35 1.31 2.93% |
The current analyst and expert consensus on Ionis Pharmaceuticals is Buy with 6 buy recommendations. The current projected Ionis Pharmaceuticals target price consensus is 51.15, with 24 analyst opinions. The most common way Ionis Pharmaceuticals analysts use to provide public buy-or-sell recommendation is financial statements analysis. They also talk to Ionis Pharmaceuticals executives, vendors, and/or customers. Ionis Pharmaceuticals buy-or-sell recommendation module provides average expert sentiment on the projected Ionis Pharmaceuticals target price to derive its highest and lowest estimates based on target price estimated volatility of 0.0. Check out Macroaxis Advice on Ionis Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Ionis Stock please use our How to Invest in Ionis Pharmaceuticals guide.
Lowest Forecast 46.55 | Highest Forecast 56.78 | Target Price 51.15 |
Ionis |
It's important to approach Ionis Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Ionis Pharmaceuticals Target Price Consensus
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Ionis target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Ionis Pharmaceuticals' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
24 | Buy |
Most Ionis analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Ionis stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Ionis Pharmaceuticals, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationIonis Pharmaceuticals Target Price Projection
Ionis Pharmaceuticals' current and average target prices are 43.35 and 51.15, respectively. The current price of Ionis Pharmaceuticals is the price at which Ionis Pharmaceuticals is currently trading. On the other hand, Ionis Pharmaceuticals' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Ionis Pharmaceuticals Market Quote on 29th of March 2024
Target Price
Analyst Consensus On Ionis Pharmaceuticals Target Price
Ionis Pharmaceuticals Analyst Ratings
Ionis Pharmaceuticals' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Ionis Pharmaceuticals stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Ionis Pharmaceuticals' financials, market performance, and future outlook by experienced professionals. Ionis Pharmaceuticals' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Ionis Pharmaceuticals price targets
Ionis Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using Ionis Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:- Look at Ionis Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Ionis Pharmaceuticals' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Ionis Pharmaceuticals Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Ionis Pharmaceuticals is a key component of Ionis Pharmaceuticals valuation and have some predictive power on the future returns of a Ionis Pharmaceuticals.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ionis Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.Cleaning Invested over 100 shares | ||
Warren Buffett Holdings Invested few shares | ||
Macroaxis Index Invested over 200 shares | ||
Momentum Invested over 40 shares | ||
Check out Macroaxis Advice on Ionis Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Ionis Stock please use our How to Invest in Ionis Pharmaceuticals guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for Ionis Stock analysis
When running Ionis Pharmaceuticals' price analysis, check to measure Ionis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ionis Pharmaceuticals is operating at the current time. Most of Ionis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ionis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ionis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ionis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Stocks Directory Find actively traded stocks across global markets | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
The data published in Ionis Pharmaceuticals' official financial statements usually reflect Ionis Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Ionis Pharmaceuticals. For example, before you start analyzing numbers published by Ionis accountants, it's critical to develop an understanding of what Ionis Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Ionis Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ionis Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Ionis Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Ionis Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Ionis Pharmaceuticals' management manipulating its earnings.